286 related articles for article (PubMed ID: 36163484)
1. Identification of the effects of COVID-19 on patients with pulmonary fibrosis and lung cancer: a bioinformatics analysis and literature review.
Li Y; Niu L
Sci Rep; 2022 Sep; 12(1):16040. PubMed ID: 36163484
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics and system biology approach to identify the influences of SARS-CoV-2 infections to idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease patients.
Mahmud SMH; Al-Mustanjid M; Akter F; Rahman MS; Ahmed K; Rahman MH; Chen W; Moni MA
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33847347
[TBL] [Abstract][Full Text] [Related]
3. Network-based identification genetic effect of SARS-CoV-2 infections to Idiopathic pulmonary fibrosis (IPF) patients.
Taz TA; Ahmed K; Paul BK; Kawsar M; Aktar N; Mahmud SMH; Moni MA
Brief Bioinform; 2021 Mar; 22(2):1254-1266. PubMed ID: 33024988
[TBL] [Abstract][Full Text] [Related]
4. [Research Progress on Pathogenic Mechanism and Potential Therapeutic Drugs of
Idiopathic Pulmonary Fibrosis Complicated with Non-small Cell Lung Cancer].
Xiao T; Bao J; Liu X; Huang H; Zhou H
Zhongguo Fei Ai Za Zhi; 2022 Oct; 25(10):756-763. PubMed ID: 36167462
[TBL] [Abstract][Full Text] [Related]
5. Identification of hub genes associated with COVID-19 and idiopathic pulmonary fibrosis by integrated bioinformatics analysis.
Chen Q; Xia S; Sui H; Shi X; Huang B; Wang T
PLoS One; 2022; 17(1):e0262737. PubMed ID: 35045126
[TBL] [Abstract][Full Text] [Related]
6. High complement protein C1q levels in pulmonary fibrosis and non-small cell lung cancer associated with poor prognosis.
Kou W; Li B; Shi Y; Zhao Y; Yu Q; Zhuang J; Xu Y; Peng W
BMC Cancer; 2022 Jan; 22(1):110. PubMed ID: 35078421
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatics-based investigation on the genetic influence between SARS-CoV-2 infections and idiopathic pulmonary fibrosis (IPF) diseases, and drug repurposing.
Islam MA; Kibria MK; Hossen MB; Reza MS; Tasmia SA; Tuly KF; Mosharof MP; Kabir SR; Kabir MH; Mollah MNH
Sci Rep; 2023 Mar; 13(1):4685. PubMed ID: 36949176
[TBL] [Abstract][Full Text] [Related]
8. Remarkable response of non-small cell lung cancer to nintedanib treatment in a patient with idiopathic pulmonary fibrosis.
Kai Y; Matsuda M; Fukuoka A; Hontsu S; Yamauchi M; Yoshikawa M; Muro S
Thorac Cancer; 2021 May; 12(9):1457-1460. PubMed ID: 33742758
[TBL] [Abstract][Full Text] [Related]
9. Surgical treatment for primary lung cancer combined with idiopathic pulmonary fibrosis.
Watanabe A; Miyajima M; Mishina T; Nakazawa J; Harada R; Kawaharada N; Higami T
Gen Thorac Cardiovasc Surg; 2013 May; 61(5):254-61. PubMed ID: 23188513
[TBL] [Abstract][Full Text] [Related]
10. Identification of common signatures in idiopathic pulmonary fibrosis and lung cancer using gene expression modeling.
Leng D; Yi J; Xiang M; Zhao H; Zhang Y
BMC Cancer; 2020 Oct; 20(1):986. PubMed ID: 33046043
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional profiles and common genes link lung cancer with the development and severity of COVID-19.
Cury SS; Oliveira JS; Biagi-Júnior CAO; Silva WA; Reis PP; Cabral-Marques O; Hasimoto EN; Freire PP; Carvalho RF
Gene; 2023 Feb; 852():147047. PubMed ID: 36379381
[TBL] [Abstract][Full Text] [Related]
12. Idiopathic pulmonary fibrosis in small cell lung cancer as a predictive factor for poor clinical outcome and risk of its exacerbation.
Koyama N; Iwai Y; Nagai Y; Aoshiba K; Nakamura H
PLoS One; 2019; 14(8):e0221718. PubMed ID: 31442290
[TBL] [Abstract][Full Text] [Related]
13. [Radiotherapy of Lung Tumours in Idiopathic Pulmonary Fibrosis].
Kolek V; Vašáková M; Šterclová M; Cwiertka K; Vrána D; Kudláček A; Skřičková J; Pešek M; Petera J
Klin Onkol; 2017; 30(4):303-306. PubMed ID: 28832178
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of ACE2 and TMPRSS2 by particulate matter and idiopathic pulmonary fibrosis: a potential role in severe COVID-19.
Li HH; Liu CC; Hsu TW; Lin JH; Hsu JW; Li AF; Yeh YC; Hung SC; Hsu HS
Part Fibre Toxicol; 2021 Mar; 18(1):11. PubMed ID: 33706759
[TBL] [Abstract][Full Text] [Related]
15. To investigate the internal association between SARS-CoV-2 infections and cancer through bioinformatics.
Shen Q; Wang J; Zhao L
Math Biosci Eng; 2022 Aug; 19(11):11172-11194. PubMed ID: 36124586
[TBL] [Abstract][Full Text] [Related]
16. MLBioIGE: integration and interplay of machine learning and bioinformatics approach to identify the genetic effect of SARS-COV-2 on idiopathic pulmonary fibrosis patients.
Tanzir Mehedi S; Ahmed K; Bui FM; Rahaman M; Hossain I; Tonmoy TM; Limon RA; Ibrahim SM; Moni MA
Biol Methods Protoc; 2022; 7(1):bpac013. PubMed ID: 35734766
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of the combination of modern medicine and traditional Chinese medicine in pulmonary fibrosis arising as a sequelae in convalescent COVID-19 patients: a randomized multicenter trial.
Lu ZH; Yang CL; Yang GG; Pan WX; Tian LG; Zheng JX; Lv S; Zhang SY; Zheng PY; Zhang SX
Infect Dis Poverty; 2021 Mar; 10(1):31. PubMed ID: 33731163
[TBL] [Abstract][Full Text] [Related]
18. Severity of COVID-19 in patients with lung cancer: evidence and challenges.
Passaro A; Bestvina C; Velez Velez M; Garassino MC; Garon E; Peters S
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737345
[TBL] [Abstract][Full Text] [Related]
19. Effect of nintedanib on non-small cell lung cancer in a patient with idiopathic pulmonary fibrosis: A case report and literature review.
Shiratori T; Tanaka H; Tabe C; Tsuchiya J; Ishioka Y; Itoga M; Taima K; Takanashi S; Tasaka S
Thorac Cancer; 2020 Jun; 11(6):1720-1723. PubMed ID: 32285615
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis.
Sinha S; Castillo V; Espinoza CR; Tindle C; Fonseca AG; Dan JM; Katkar GD; Das S; Sahoo D; Ghosh P
bioRxiv; 2022 Jul; ():. PubMed ID: 34873597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
